Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
06/2005
06/15/2005CN1626135A Medication for treating cough and gasp
06/15/2005CN1626134A Medication for treating chronic rhinitis and nasal sinuitis
06/15/2005CN1626114A Spray agent of dried powder in use for diminishing inflammation of mucous membrane and preparation method
06/15/2005CN1626112A Method for preparing external and internal remedies for treating diseases of AIDS virus, burn and scald, and usage
06/15/2005CN1626106A Medication for preventing and treating diseases of pigs
06/15/2005CN1626091A Combination of medicine for colds in use for treating non-phlegmatic cough and preparation method
06/15/2005CN1626076A Andrographolide drop pills and preparation method
06/15/2005CN1626072A Powder and injection preparation of new houttuynine sodium bisulfite and preparation method
06/15/2005CN1626071A Propylgallate injection administration does type and preparation method
06/15/2005CN1206230C 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy
06/15/2005CN1206228C N-heterocyclic derivatives as NOS inhibitors
06/15/2005CN1206219C N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/15/2005CN1206205C Process for preparing R-salbutamol tartrate
06/15/2005CN1205978C Medicine composition for treating cold
06/15/2005CN1205972C Chinese medicnie preparation for preventing and treating throat and oral cavity diseases and preparation method
06/15/2005CN1205969C Ointment of Chinese traditional medicine for curing fever and cough
06/15/2005CN1205952C Chinese-medicinal oral liquid for treating rhinitis and nasosinusitis and its preparing process
06/15/2005CN1205943C Application of citrus paradisi Micf seed in preparing medicine for resisting SARS virus
06/15/2005CN1205935C Highly selective norepinephrine reuptake inhibitors and methods of using same
06/14/2005US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
06/14/2005US6906073 Piperazine CCR-3 receptor antagonists
06/14/2005US6906066 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/14/2005US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents
06/14/2005US6905820 Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/14/2005US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases
06/14/2005US6905684 Preventives and remedies for diffuse lung diseases
06/14/2005CA2274591C Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them
06/09/2005WO2004012671A3 Substituted furo [2,3-b] pyridine derivatives
06/09/2005US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor
06/09/2005US20050124691 Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
06/09/2005US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms
06/09/2005US20050124686 Polyether brevetoxin derivatives as a treatment for cystic fibrosis, mucociliary dysfunction, and pulmonary diseases
06/09/2005US20050124680 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
06/09/2005US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity
06/09/2005US20050124649 Deazapurines and uses thereof
06/09/2005US20050124648 Triazolo-quinolin derivatives useful as adenosine receptor ligands
06/09/2005US20050124624 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for threating ang ii-mediated diseases
06/09/2005US20050124621 Novel inhibitors of kinases
06/09/2005US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders
06/09/2005US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
06/09/2005US20050124574 Purine derivatives
06/09/2005US20050124561 Administering fungicide for mucous membrane; asthma therapy
06/09/2005US20050124543 Heterologous polypeptide of the TNF family
06/09/2005US20050124538 for prophylaxis, prevention, treatment or therapy of inflammatory conditions or allergic reactions in a mammal; binds bacterial lipopeptide
06/09/2005US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
06/09/2005US20050124004 Histamine receptor h3 polynucleotides
06/09/2005US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders
06/09/2005US20050123910 Nucleotide sequences coding prolyl oligopeptidase (DPP10) for use in identifying modulator which prevent and treat allergies, asthma, skin and inflammatory diseases
06/09/2005US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches
06/09/2005US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage
06/09/2005US20050123568 Chromatographic purification steps using unbuffered aqueous bases as eluent and subsequent neutralization; low side effect for specific immunotherapy of this pollen allergy; reduced immunoglobulin E binding with simultaneous retention of therapeutically relevant T-cell stimulation
06/09/2005US20050123536 Treatment of immunological disorders using anti-dc30 antibodies
06/09/2005US20050123523 Immunostimulatory nucleic acid molecules
06/09/2005US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis
06/09/2005US20050121024 Spray device
06/09/2005CA2543858A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
06/08/2005EP1538162A2 Compositions for altering mucus secretion
06/08/2005EP1538160A1 Substituted Isoquinolin-3-carboxyamides, their preparation and medical use
06/08/2005EP1537879A1 Preventive and/or therapeutic drugs for asthma
06/08/2005EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof
06/08/2005EP1537109A1 Novel benzonaphthyridines
06/08/2005EP1537100A1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
06/08/2005EP1537096A2 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
06/08/2005EP1537090A1 Chromone derivatives as matrix metalloproteinase inhibitors
06/08/2005EP1537086A2 Novel phenanthridines
06/08/2005EP1537084A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1537069A2 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE
06/08/2005EP1536816A2 Amelioration of effects of cigarette smoke
06/08/2005EP1536813A2 Compositions and methods comprising protein activated receptor antagonists
06/08/2005EP1536798A1 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors
06/08/2005EP1536797A1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
06/08/2005EP1465854A4 Chalcone derivatives and their use to treat diseases
06/08/2005EP1458706A4 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
06/08/2005EP1432427B1 Composition of hypochlorous acid and its applications
06/08/2005EP1373269B1 Jun kinase inhibitors
06/08/2005EP1373231B1 3-heterocyclyl-propano-hydroxamic acid as pcp inhibitors
06/08/2005EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators
06/08/2005EP1259514B1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1089735B1 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists
06/08/2005EP0849256B1 Amide compounds and use of the same
06/08/2005CN2703520Y Medicinal plaster for pneumonia
06/08/2005CN1625603A Genetic polymorphisms in the preprotachykinin gene
06/08/2005CN1625557A Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
06/08/2005CN1625556A Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions
06/08/2005CN1625554A Amides of aminoalkyl substituted azetidines, pyrrolidines, piperidines and azepanes
06/08/2005CN1625400A 2, 4-pyrimidinediamine compounds and their uses
06/08/2005CN1625392A Composition for inhalation
06/08/2005CN1623985A Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
06/08/2005CN1623599A Xiaoyao soft capsule and its preparation technology
06/08/2005CN1623593A Solid instant preparation extracted from ginkgo leaf and its preparing process
06/08/2005CN1623589A Deal apple chrysanthemum preparation for treating throat disease
06/08/2005CN1623565A Method of preparing Chinese patent drug for treating asthma
06/08/2005CN1623564A Medicine for treating asthmatic tracheitis
06/08/2005CN1623547A Medical use of artificial lywrine
06/08/2005CN1623534A Use of creatine
06/08/2005CN1205210C 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/08/2005CN1205205C Sodium-hydrogen exchanger type 1 inhibitor crystals
06/08/2005CN1205175C Application of amine derivative in medicine prepared with the function of anti-pulmonary hypertension
1 ... 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 ... 878